GlassScriptPhysician profile
Taylor M Crum
NPI 1710629159
$1,933.35
in general payments reported to CMS, 2019-2025
24 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,655 · 2023: $21.56 · 2024: $75.81 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $286.36 | 2022 | |
| Abbvie INC. | $183.50 | 2022-2023 | |
| Heartflow, INC. | $157.91 | 2025 | |
| Almatica Pharma LLC | $136.35 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $134.13 | 2022 | |
| Sanofi-Aventis U.S. LLC | $106.66 | 2022 | |
| Novo Nordisk INC | $98.92 | 2022 | |
| Pfizer INC. | $97.72 | 2022 | |
| Astellas Pharma US INC | $85.00 | 2022 | |
| Boston Scientific Corporation | $74.58 | 2022-2025 | General - Pain Management |
| Merck Sharp & Dohme LLC | $73.84 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $68.60 | 2022-2024 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $64.04 | 2022 | |
| Glaxosmithkline, LLC. | $59.71 | 2022 | |
| Novartis Pharmaceuticals Corporation | $59.39 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.97 | 2022 | |
| Janssen Pharmaceuticals, INC | $42.41 | 2022 | |
| Ironwood Pharmaceuticals, INC | $31.92 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.30 | 2022-2024 | Eliquis |
| Dexcom, INC. | $28.28 | 2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $21.42 | 2022 | |
| Irhythm Technologies, INC. | $16.05 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.90 | 2022 | |
| Corium, LLC | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Crum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.